Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Liver Neoplasms 2Carcinoma, Hepatocellular 2Kidney Neoplasms 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Radiosurgery 7lenvatinib 5Radiofrequency Ablation 5Electroporation 5Radiotherapy 3Patient Navigation 3Laparoscopy 3Hepatectomy 3Exercise 3sintilimab 2perflutren 2Surgical Procedures, Operative 2Standard of Care 2Proton Therapy 2Nutritional Status 2Magnetic Resonance Spectroscopy 2Liver Transplantation 2Injections 2Dextrins 2Cryosurgery 2Control Groups 2Bupivacaine 2Anesthesia, General 2toripalimab 1tislelizumab 1seocalcitol 1pembrolizumab 1motexafin gadolinium 1gadofosveset trisodium 1gadobutrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Liver Neoplasms × perflutren × Clear all
NCT02424955 2023-07-11

Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Stanford University

Phase NA Completed
11 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00584402 2017-07-11

Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation

University of California, Davis

Phase NA Completed
8 enrolled 5 charts
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡